A groundbreaking experimental pancreatic cancer vaccine is generating excitement after early trial results showed a lasting immune response in most high-risk patients, offering new hope against one of the deadliest cancers. Post navigation Health expert says DON’T PANIC as parasite cases raise concern Fauci to face off with lawmakers over COVID origins: ‘LOOK AT EVERYTHING’